The Effectiveness of Self-Management Education and Telephone Follow-up in Patient with COPD Exacerbation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorKirsehir Ahi Evran Universitesi

About this trial

According to the 2024 GOLD guidelines, Chronic Obstructive Pulmonary Disease (COPD) is defined as heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production, and/or exacerbations) due to abnormalities of the airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction. COPD is one of the leading causes of mortality and morbidity in Turkey and worldwide. Since COPD is an incurable and lifelong disease, it is important for patients to have high levels of self-management.

The main questions it aims to answer are:

1. Does self-management education and telephone follow-up intervention effect self-care agency and symptom management in people with COPD exacerbation? 2. Does self-management education effect self-care agency and symptom management in people with COPD exacerbation? This study will evaluate the effect of self-management education and telephone follow-up on self-care agency and symptom management. Patients hospitalized with COPD exacerbation will be trained in the hospital and will be followed up by phone call after discharge. During the study, 3 groups were planned; Group 1 will be educated and followed up by telephone Group 2 will only receive education and no telephone follow-up. Group 3 will not receive education and telephone follow-up, only standard care. It is planned to collect the data from the patients at the beginning of the study, at 1, 3 and 6 months.

Main outcomes:

* Level of self-care agency * Level of symptom management The results obtained will be interpreted by comparing between 3 groups.

Eligibility criteria

Qualifiers

Diagnosed with COPD for the last 1 year

Diagnosis of Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage III or IV COPD documented by pulmonary function testing

Patients hospitalized for acute exacerbation of COPD;

Hospitalized for at least 3 days

Disqualifiers

Under 18 years old

Withdrawal from the study at any phase

Inability to be contacted by phone/mobile phone,

Patient death

Trial design

Treatments tested in this trial

  • Self Management Education
  • Telephone Follow-up

Treatment groups

150 Participants
are divided into 3 treatment groups